US identifies patients at higher stroke risk

Publication
Article
Diagnostic Imaging EuropeDiagnostic Imaging Europe Vol 26 No 6
Volume 26
Issue 6

Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.

Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.

The technique might also be useful in selecting patients with asymptomatic carotid stenosis who are likely to benefit from endarterectomy.

Embolic signs-short-duration, high-energy signals-were present in 77 of 467 patients at baseline. The hazard ratio for the risk of ipsilateral stroke and transient ischemic attack from baseline to two years in patients with embolic signals compared with those without was 2.54. The hazard ratio for ipsilateral stroke alone was 5.57 (Lancet DOI:10.1016/S1474-4422(10)70120-4).

Absolute annual risk of ipsilateral stroke or a transient ischemic attack between baseline and two years was 7.13% in patients with embolic signals and 3.04% in those without. The absolute annual risk of ipsilateral stroke alone was 3.62% in patients with embolic signals and 0.7% in those without.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.